MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00198-025-07572-4

Медицинская библиотека · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025

Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis.

Tang Ning, Zhang Jing, Liu Xinyan, Yao Dongchen, Zhang Xinyi, Ye Pengpeng, Liu Tingzhuo, Liang Jinyu, Yang Wang, Armstrong Elizabeth, Mitchell Paul, Ivers Rebecca, Wong Ronald Man Yeung, Wang Yongchen, Yang Minghui, Tian Maoyi

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

UNLABELLED: Continuing antiplatelets during hip fracture surgery may be safe for older adults, while early surgery after discontinuation reduces hospital stay without adverse outcomes.

PURPOSE: The safety of continuing antiplatelets or direct oral anticoagulants (DOACs) before surgery in older patients with hip fractures remains uncertain. The feasibility of timely surgery after discontinuation also warrants further investigation.

METHODS

We included studies of hip fracture patients aged ≥ 65 years taking antiplatelets or DOACs, comparing continuation versus discontinuation, or early versus delayed surgery. MEDLINE, EMBASE, Cochrane Library, and Web of Science were searched to November 2024. Risk of bias was assessed using the Newcastle-Ottawa Scale. Meta-analyses were conducted using a random-effects model to pool effect estimates. This study was registered with PROSPERO (CRD42022378334).

RESULTS

Thirteen observational studies from nine countries involving 885 patients were included. There were no significant differences in transfusion rates in patients who continued the medication (Odds Ratio [OR] = 0.87; 95% Confidence Interval [CI]: 0.37 to 2.03). Surgery within 48 h of antiplatelet discontinuation was associated with shorter hospital stay (mean difference = - 5.71 days; 95% CI: - 8.36 to - 3.06) compared to those with delayed surgery, with no increase in transfusion (OR = 0.75; 95% CI: 0.04 to 13.73) and in-hospital mortality (OR = 0.49; 95% CI: 0.02 to 13.52). For DOAC users, no significant differences were observed in transfusion (OR = 1.09; 95% CI: 0.56 to 2.09) and 30-day mortality (OR = 1.53; 95% CI: 0.45 to 5.19) for early versus delayed surgery.

CONCLUSIONS

Surgery without discontinuing antiplatelets may be safe. Early surgery after discontinuing antiplatelets could reduce hospital stays without adverse outcomes. Randomized trials are needed to confirm these findings.

Для цитирования: Tang Ning, Zhang Jing, Liu Xinyan, Yao Dongchen, Zhang Xinyi, Ye Pengpeng, Liu Tingzhuo, Liang Jinyu, Yang Wang, Armstrong Elizabeth, Mitchell Paul, Ivers Rebecca, Wong Ronald Man Yeung, Wang Yongchen, Yang Minghui, Tian Maoyi. Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis.. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2025. DOI: 10.1007/s00198-025-07572-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.